Virginie Marty Selected Research

Virginie Marty Research Topics

12	Neoplasms (Cancer) 01/2024 - 02/2011
3	Prader-Willi Syndrome (Syndrome, Prader-Willi) 01/2023 - 08/2007
2	Carcinoma (Carcinomatosis) 04/2024 - 12/2013
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2016
2	Circulating Neoplastic Cells 01/2020 - 01/2016
2	Neuroblastoma 10/2017 - 01/2016
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2024
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Bulimia (Binge Eating) 01/2023
1	Tertiary Lymphoid Structures 10/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 10/2022
1	Infections 10/2022
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2022
1	Hodgkin Disease (Hodgkin's Disease) 01/2021
1	Melanoma (Melanoma, Malignant) 12/2017
1	Hypoxia (Hypoxemia) 12/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 12/2013
1	Inflammation (Inflammations) 02/2011

3	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 09/2020
2	pembrolizumabIBA 10/2022 - 12/2017
2	PlatinumIBA 01/2022 - 01/2022
2	B7-H1 AntigenIBA 01/2021 - 10/2017
2	Proteins (Proteins, Gene)FDA Link 12/2017 - 01/2010
1	Serotonin (5 Hydroxytryptamine)IBA 01/2023
1	Cocaine (Cocaine HCl)IBA 01/2023
1	trastuzumab deruxtecanIBA 01/2023
1	Immune Checkpoint InhibitorsIBA 10/2022
1	ChemokinesIBA 10/2022
1	Alanine (L-Alanine)FDA Link 01/2022
1	Pattern Recognition ReceptorsIBA 01/2022
1	Threonine (L-Threonine)FDA Link 01/2022
1	olaparibIBA 01/2022
1	enzalutamideIBA 01/2020
1	GlycogenIBA 12/2017
1	Anaplastic Lymphoma KinaseIBA 01/2016
1	NVP-TAE684IBA 01/2016
1	LigandsIBA 01/2016
1	MidkineIBA 01/2016
1	pleiotrophin (HARP)IBA 01/2016
1	Histocompatibility Antigens Class IIBA 12/2013
1	scinderinIBA 12/2013
1	Ephrin-A1 (Ephrin A1)IBA 12/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2011
1	Alkylating AgentsIBA 02/2011
1	snRNP Core ProteinsIBA 01/2010
1	DNA-like RNA (D-RNA)IBA 08/2007